Albert M. Kim
Cardiac Electrophysiology | Cardiology
1400 Vfw Pkwy
Va Boston Healthcare System, Cardiology
Boston, MA 02132
Va Boston Healthcare System, Cardiology
Boston, MA 02132
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
A phase 2a, randomized, double-blind, placebo-controlled, three-arm, parallel-group study to assess the efficacy, safety, tolerability and pharmacodynamics of PF-06835919 in patients with non-alcoholic fatty liver disease and type 2 diabetes.
Journal: Diabetes, obesity & metabolism
Published: August 31, 2022
ACC inhibitor alone or co-administered with a DGAT2 inhibitor in patients with non-alcoholic fatty liver disease: two parallel, placebo-controlled, randomized phase 2a trials.
Journal: Nature medicine
Published: September 11, 2020
Myeloperoxidase inhibition in mice alters atherosclerotic lesion composition.
Journal: PloS one
Published: November 20, 2018
Targeting diacylglycerol acyltransferase 2 for the treatment of nonalcoholic steatohepatitis.
Journal: Science translational medicine
Published: November 06, 2018
Lipid-Reduction Variability and Antidrug-Antibody Formation with Bococizumab.
Journal: The New England journal of medicine
Published: March 18, 2017
New medicinal products for chronic heart failure: advances in clinical trial design and efficacy assessment.
Journal: European journal of heart failure
Published: November 18, 2016
Once-weekly administration of a long-acting fibroblast growth factor 21 analogue modulates lipids, bone turnover markers, blood pressure and body weight differently in obese people with hypertriglyceridaemia and in non-human primates.
Journal: Diabetes, obesity & metabolism
Published: October 31, 2016
Erratum to "Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency" [Eur J Heart Fail 2016;18:482-489].
Journal: European journal of heart failure
Published: June 22, 2016
Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency.
Journal: European journal of heart failure
Published: October 01, 2015
Showing 1-10 of 10
Last Updated: 09/26/2026